查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1684379

哺乳动物细胞发酵技术市场，按类型、按应用、按最终用途、按国家和地区 - 2025 年至 2032 年全球行业分析、市场规模、市场份额和预测

Mammalian Cell Fermentation Technology Market, By Type, By Application, By End-use, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 311 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年哺乳动物细胞发酵技术市场规模价值为 507.8943 亿美元，2025 年至 2032 年的复合年增长率为 8.99%。

哺乳动物细胞发酵技术市场-市场动态

生物製剂和生物相似药需求不断成长，推动市场成长

由于对生物相似药和生物製剂的需求不断增加，哺乳动物细胞发酵技术产业正在经历显着的成长。这些治疗对于控制各种疾病（包括传染病、癌症和自体免疫疾病）非常重要。此外，随着製药公司对新型生物製剂的研发投入加大，哺乳动物细胞发酵技术也不断扩展。然而，限制该技术广泛应用的一个重要因素是其製造流程的高成本。此外，癌症、糖尿病和心臟病等慢性病的增加导致哺乳动物细胞发酵技术市场的成长。由于许多疾病需要长期治疗（通常采用生物製剂），因此对哺乳动物细胞发酵技术的需求持续存在。因此，由于对生物相似药和生物製剂的需求不断增长以及慢性病的增加，哺乳动物细胞发酵技术市场预计未来几年将会成长。

哺乳动物细胞发酵技术市场-关键见解

根据我们的研究分析师的分析，预测期内（2025-2032 年），全球市场预计年复合成长率约为 8.99%

根据类型细分，预计中国仓鼠卵巢 (CHO) 细胞发酵将在 2024 年占据最大市场份额

根据应用细分，单株抗体是 2024 年的主要应用

根据最终用途细分，CMO 和 CDMO 是 2024 年的主要最终用途

从地区来看，北美是 2024 年最大的收入来源

哺乳动物细胞发酵技术市场-細項分析：

全球哺乳动物细胞发酵技术市场根据类型、应用、最终用途和地区进行细分。

市场依类型分为五类：小仓鼠肾（BHK）细胞发酵、中国仓鼠卵巢（CHO）细胞发酵、人类胚胎肾（HEK）细胞发酵、鼠骨髓瘤细胞发酵等。中国仓鼠卵巢（CHO）细胞发酵领域预计将占据市场主导地位。 CHO 细胞因其能够有效製造复杂的治疗性蛋白质而引起了广泛关注。此外，需求的成长可归因于多种因素，例如培养基和条件的最佳化、增强细胞株发育的基因工程技术的进步以及强大的监管环境。

根据应用，市场分为六类：酵素、荷尔蒙、单株抗体、重组蛋白、疫苗、其他。单株抗体领域可能占据最高的市场份额，因为高采用率可以归因于抗体在诊断和治疗应用中发挥的关键作用，从而导致对稳健生产方法的需求不断增长。此外，细胞株开发、生物反应器技术和生物加工技术的进步，带来了更好的产品品质、更高的产量和更高效的生产过程，推动了该领域的爆炸式扩张。同样，对精准标靶治疗的需求和慢性病的日益普及也刺激了对哺乳动物抗体的需求。

根据最终用途，市场分为三类：学术和研究机构、生物製药公司以及 CMO 和 CDMO。由于 CDMO 和 CMO 擅长的复杂製造技术，CMO 和 CDMO 行业很可能在预测期内保持主导地位。此外，品质标准和监管要求更加严格，因此製药企业需要与信誉良好的 CMO 和 CDMO 合作，以保持满足这些要求的能力。

哺乳动物细胞发酵技术市场-地理洞察

北美占据哺乳动物细胞发酵技术市场的最大份额。市场的成长归功于该地区高度发展的医疗保健产业、有利的政府法规以及重要生物製药公司的强大影响力。此外，对生物製剂和生物相似药的需求不断增长以及慢性病发病率的上升是推动该地区市场成长的因素。

由于能够以较低成本获得训练有素的员工、有利的监管环境以及跨国公司的投资不断增加，亚太地区可能会快速成长。

哺乳动物细胞发酵技术市场-竞争格局：

哺乳动物细胞发酵市场受到细胞培养技术进步的推动。哺乳动物细胞发酵技术在众多应用领域的需求不断增长，为主要参与者创造了各种市场机会。这些行业参与者主要采用涉及收购、合作、伙伴关係和合併等多种策略来建立全球影响力并保持市场竞争。此外，持续进行的生物加工方法研发工作以及生物製造基础设施支出的增加也促进了市场的进步。例如，2023年1月，復星医药与上海復宏汉霖生物科技股份有限公司在美国签署独家授权协议，将復宏汉霖自主开发的抗PD-1单株抗体serplulimab商业化。这标誌着復星医药在美国发展的重要转捩点。

最新动态：

2023 年 7 月，Lonza 推出了 TheraPRO(R) CHO 培养基系统，这是一个创新的细胞培养平台，与 GS-CHO 细胞系一起使用时可简化程序并优化生产力和蛋白质品质。该技术的推出支持生产治疗性蛋白质的生物技术和製药公司提高产品质量，同时缩短产品上市时间。

目录

第 1 章：哺乳动物细胞发酵技术市场概述

  • 研究范围
  • 市场估计年限

第 2 章：执行摘要

  • 市场片段
    • 哺乳动物细胞发酵技术市场片段（按类型）
    • 哺乳动物细胞发酵技术市场片段（依应用）
    • 哺乳动物细胞发酵技术市场片段（依最终用途）
    • 哺乳动物细胞发酵技术市场（按国家/地区）
    • 哺乳动物细胞发酵技术市场片段（按地区）
  • 竞争洞察

第 3 章：哺乳动物细胞发酵技术关键市场趋势

  • 哺乳动物细胞发酵技术市场驱动因素
    • 市场驱动因素的影响分析
  • 哺乳动物细胞发酵技术市场限制
    • 市场限制的影响分析
  • 哺乳动物细胞发酵技术的市场机会
  • 哺乳动物细胞发酵技术市场未来趋势

第 4 章：哺乳动物细胞发酵技术产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景规划
  • 规范架构分析

第五章：哺乳动物细胞发酵技术市场：地缘政治紧张局势升级的影响

  • 新冠肺炎疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第 6 章：哺乳动物细胞发酵技术市场格局

  • 哺乳动物细胞发酵技术市占分析，2024 年
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第 7 章：哺乳动物细胞发酵技术市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 幼仓鼠肾（BHK）细胞发酵
    • 中国仓鼠卵巢（CHO）细胞发酵
    • 人类胚胎肾 (HEK) 细胞发酵
    • 鼠骨髓瘤细胞发酵
    • 其他的

第 8 章：哺乳动物细胞发酵技术市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 酵素
    • 荷尔蒙
    • 单株抗体
    • 重组蛋白
    • 疫苗
    • 其他的

第 9 章：哺乳动物细胞发酵技术市场 - 依最终用途

  • 概述
    • 按最终用途分類的细分市场份额分析
    • 学术及研究机构
    • 生物製药公司
    • CMO 和 CDMO

第 10 章：哺乳动物细胞发酵技术市场-按地区

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美哺乳动物细胞发酵技术主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模和预测（按类型）
    • 北美市场规模与预测，按应用划分
    • 北美市场规模及预测（依最终用途）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲哺乳动物细胞发酵技术主要製造商
    • 欧洲市场规模及预测（按国家）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模和预测，按应用
    • 欧洲市场规模及预测（依最终用途）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区哺乳动物细胞发酵技术主要製造商
    • 亚太地区市场规模及预测（依国家/地区划分）
    • 亚太地区市场规模及预测（按类型）
    • 亚太地区市场规模及预测（按应用划分）
    • 亚太地区市场规模及预测（依最终用途划分）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲 (LATAM)
    • 概述
    • 拉丁美洲哺乳动物细胞发酵技术主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（按类型）
    • 拉丁美洲市场规模及预测（按应用划分）
    • 拉丁美洲市场规模及预测（依最终用途划分）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲 (MEA)
    • 概述
    • 中东和非洲哺乳动物细胞发酵技术主要製造商
    • MEA 市场规模及预测（依国家/地区划分）
    • MEA 市场规模和预测（按类型）
    • MEA 市场规模及预测（按应用）
    • MEA 市场规模及预测（依最终用途）
    • 沙乌地阿拉伯
    • 阿联酋
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其他地区

第 11 章：主要供应商分析-哺乳动物细胞发酵技术产业

  • 竞争性基准化分析
    • Competitive Dashboard
    • Competitive Positioning
  • 公司简介
    • AstraZeneca
    • Danaher
    • Thermo Fisher Scientific, Inc.
    • Regeneron Pharmaceuticals
    • Merck KGaA
    • Lonza
    • Gilead Sciences
    • F. Hoffmann-La Roche Ltd
    • Moderna, Inc
    • Bristol-Myers Squibb
    • Amgen
    • Sartorius AG
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4754

REPORT HIGHLIGHT

Mammalian cell fermentation technology Market size was valued at US$ 50,789.43 Million in 2024, expanding at a CAGR of 8.99% from 2025 to 2032.

Mammalian cells are widely used for producing therapeutic proteins like vaccines, monoclonal antibodies, and other biologics, along with various source materials like Human Embryonic Kidney (HEK) cells, Chinese Hamster Ovary (CHO) cells, and others. The mammalian cell fermentation technology industry will likely see significant growth in the forecasted years due to several factors, such as the rising demand for biosimilars and biologics, the increasing prevalence of chronic diseases, and advancements in mammalian cell culture techniques.

Mammalian Cell Fermentation Technology Market- Market Dynamics

Increasing demand for biologics and biosimilars to propel market growth

The mammalian cell fermentation technology industry is witnessing a significant rise due to the rising demand for biosimilars and biologics. These treatments are important in managing various conditions, including infectious diseases, cancer, and autoimmune conditions. Additionally, mammalian cell fermentation technology keeps expanding as pharmaceutical firms invest more in the creation of novel biologics. However, a vital factor restraining the widespread use of this technology is the high expenses associated with its manufacturing process. Furthermore, the rise in chronic diseases like cancer, diabetes, and heart disease resulted in a growth in the mammalian cell fermentation technology market. There is an ongoing demand for mammalian cell fermentation technologies as many diseases need long-term treatment, often with biologics. As a result, the market for mammalian cell fermentation technology is projected to grow over the coming years owing to the constant demand for biosimilars and biologics along with the rise in chronic illnesses.

Mammalian Cell Fermentation Technology Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.99% over the forecast period (2025-2032)

Based on type segmentation, Chinese hamster ovary (CHO) cell fermentation was predicted to show maximum market share in the year 2024

Based on application segmentation, monoclonal antibodies was the leading application in 2024

Based on end-use segmentation, CMOs & CDMOs was the leading end-use in 2024

On the basis of region, North America was the leading revenue generator in 2024

Mammalian Cell Fermentation Technology Market- Segmentation Analysis:

The global mammalian cell fermentation technology market is segmented on the basis of type, application, end-use, and region.

The market is divided into five categories based on type: baby hamster kidney (BHK) cell fermentation, chinese hamster ovary (CHO) cell fermentation, human embryonic kidney (HEK) Cell fermentation, murine myeloma cell fermentation, and others. The Chinese hamster ovary (CHO) cell fermentation sector is expected to dominate the market. CHO cells have prompted immense attention because of their ability to efficiently manufacture complex therapeutic proteins. Additionally, the rise in demand can be attributed to various factors such as the optimization of culture media and conditions, advancements in genetic engineering techniques for enhancing cell line development, and a robust regulatory environment.

The market is divided into six categories based on application: enzymes, hormones, monoclonal antibodies, recombinant proteins, vaccines, others. The monoclonal antibodies segment is likely to hold the highest market share as high adoption can be attributed to the crucial role that antibodies play in diagnostic and therapeutic applications, leading to growing demand for robust production methods. In addition, advancements in cell line development, bioreactor technologies, and bioprocessing techniques, leading to better product quality, higher yields, and efficient production processes, have fueled the segment's explosive expansion. Likewise, the need for precisely targeted therapies and the increasing prevalence of chronic diseases have also fueled the demand for mammalian antibodies.

The market is divided into three categories based on end-use: academic & research institutes, biopharmaceutical companies, and CMOs & CDMOs. The CMOs & CDMOs sector is likely to maintain its dominance during the forecast period due to the complex manufacturing techniques that CDMOs and CMOs specialize in. These organizations provide a simplified and affordable solution for businesses aiming to outsource their manufacturing processes, allowing them to concentrate on development and research. Moreover, quality standards and regulatory requirements are more stringent, thereby pharmaceutical businesses to collaborate with reputable CMOs and CDMOs that maintain the proficiency to comply with these demands.

Mammalian Cell Fermentation Technology Market- Geographical Insights

North America accounts for the largest share of the mammalian cell fermentation technology market. The market growth is attributed to the region's highly developed healthcare sector, favorable government regulations, and a strong presence of significant biopharmaceutical companies. Moreover, the rising demand for biologics and biosimilars and the rising incidence of chronic illnesses are attributed to driving the region's market growth.

The Asia Pacific region is likely to increase at a swift rate owing to the accessibility of trained staff at a reduced cost, the favorable regulatory environment, and rising investments by multinational corporations.

Mammalian Cell Fermentation Technology Market- Competitive Landscape:

The market for fermenting mammalian cells is being driven by technological advancements in cell culture. The rising demand for mammalian cell fermentation technology for numerous applications has created various market possibilities for major players to capitalize on. These industry players primarily adopt several strategies that involve acquisitions, collaborations, partnerships, and mergers to establish a global footprint and maintain market competition. Moreover, the market's progress is fostered by the ongoing research and development efforts to enhance bioprocessing methods, along with the rising spending on biomanufacturing infrastructure. For instance, in January 2023, Fosun Pharmahas signed an exclusive license agreement with Shanghai Henlius Biotech, Inc. in the United States (US) for the commercialization of Henlius independently developed anti-PD-1 monoclonal antibody (mAb) serplulimab. This marks a significant turning point for Fosun Pharma's development in the US.

Recent Developments:

In July 2023, Lonza launched the TheraPRO(R) CHO Media System, an innovative cell culture platform that streamlines procedures and optimizes productivity and protein quality when utilized with GS-CHO cell lines. The launch of this technology supports biotechnology and pharmaceutical companies that manufacture therapeutic proteins to enhance product quality while streamlining time-to-market.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • AstraZeneca
  • Danaher
  • Thermo Fisher Scientific, Inc.
  • Regeneron Pharmaceuticals
  • Merck KGaA
  • Lonza
  • Gilead Sciences
  • F. Hoffmann-La Roche Ltd
  • Moderna, Inc
  • Bristol-Myers Squibb
  • Amgen
  • Sartorius AG
  • Others

GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Baby Hamster Kidney (BHK) Cell Fermentation
  • Chinese Hamster Ovary (CHO) Cell Fermentation
  • Human Embryonic Kidney (HEK) Cell Fermentation
  • Murine Myeloma Cell Fermentation
  • Others

GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Enzymes
  • Hormones
  • Monoclonal Antibodies
  • Recombinant Proteins
  • Vaccines
  • Others

GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

  • Academic & Research Institutes
  • Biopharmaceutical Companies
  • CMOs & CDMOs

GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Mammalian Cell Fermentation Technology Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Mammalian Cell Fermentation Technology Market Snippet by Type
    • 2.1.2. Mammalian Cell Fermentation Technology Market Snippet by Application
    • 2.1.3. Mammalian Cell Fermentation Technology Market Snippet by End-use
    • 2.1.4. Mammalian Cell Fermentation Technology Market Snippet by Country
    • 2.1.5. Mammalian Cell Fermentation Technology Market Snippet by Region
  • 2.2. Competitive Insights

3. Mammalian Cell Fermentation Technology Key Market Trends

  • 3.1. Mammalian Cell Fermentation Technology Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Mammalian Cell Fermentation Technology Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Mammalian Cell Fermentation Technology Market Opportunities
  • 3.4. Mammalian Cell Fermentation Technology Market Future Trends

4. Mammalian Cell Fermentation Technology Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Mammalian Cell Fermentation Technology Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Mammalian Cell Fermentation Technology Market Landscape

  • 6.1. Mammalian Cell Fermentation Technology Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Mammalian Cell Fermentation Technology Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024&2032 (%)
    • 7.1.2. Baby Hamster Kidney (BHK) Cell Fermentation
    • 7.1.3. Chinese Hamster Ovary (CHO) Cell Fermentation
    • 7.1.4. Human Embryonic Kidney (HEK) Cell Fermentation
    • 7.1.5. Murine Myeloma Cell Fermentation
    • 7.1.6. Others

8. Mammalian Cell Fermentation Technology Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024&2032 (%)
    • 8.1.2. Enzymes
    • 8.1.3. Hormones
    • 8.1.4. Monoclonal Antibodies
    • 8.1.5. Recombinant Proteins
    • 8.1.6. Vaccines
    • 8.1.7. Others

9. Mammalian Cell Fermentation Technology Market - By End-use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-use, 2024&2032 (%)
    • 9.1.2. Academic & Research Institutes
    • 9.1.3. Biopharmaceutical Companies
    • 9.1.4. CMOs & CDMOs

10. Mammalian Cell Fermentation Technology Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Mammalian Cell Fermentation Technology Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Mammalian Cell Fermentation Technology Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Mammalian Cell Fermentation Technology Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Mammalian Cell Fermentation Technology Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Mammalian Cell Fermentation Technology Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Mammalian Cell Fermentation Technology Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. AstraZeneca
    • 11.2.2. Danaher
    • 11.2.3. Thermo Fisher Scientific, Inc.
    • 11.2.4. Regeneron Pharmaceuticals
    • 11.2.5. Merck KGaA
    • 11.2.6. Lonza
    • 11.2.7. Gilead Sciences
    • 11.2.8. F. Hoffmann-La Roche Ltd
    • 11.2.9. Moderna, Inc
    • 11.2.10. Bristol-Myers Squibb
    • 11.2.11. Amgen
    • 11.2.12. Sartorius AG
    • 11.2.13. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us